Viewing Study NCT01458535


Ignite Creation Date: 2025-12-24 @ 10:38 PM
Ignite Modification Date: 2026-06-20 @ 7:12 PM
Study NCT ID: NCT01458535
Status: COMPLETED
Last Update Posted: 2016-07-11
First Post: 2011-09-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)
Sponsor: AbbVie (prior sponsor, Abbott)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C Virus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Genotype 1 View
None Genotype 2 View
None Genotype 3 View
None Hepatitis C Virus View
None ABT-450/r View
None Ribavirin View
None ABT-267 View
None Ombitasvir View
None Paritaprevir View